Literature DB >> 3509797

Growth of osteoclast precursor-like cells from whole mouse bone marrow: inhibitory effect of CSF-1.

F P van de Wijngaert1, M C Tas, J W van der Meer, E H Burger.   

Abstract

We studied the growth of mononuclear phagocytes (MPs) and mononuclear osteoclast precursor-resembling (OCP-like) cells from freshly isolated whole mouse bone marrow. Expression of tartrate-resistant acid phosphatase (TRAcP) served as a general marker for the identification of OCP-like cells. Bone resorbing capacity of the cultured cells was studied in a coculture assay with periost-free fetal bone rudiments. Freshly isolated mouse bone marrow contained approximately 30 OCP-like cells and 1100 MPs per 10(6) nucleated bone marrow cells. OCP-like cell numbers did not increase in suspension cultures containing macrophage-colony stimulating factor (CSF-1), in contrast to the number of MPs which increased strongly. OCP-like cell numbers however did increase in monolayer cultures, which also allowed anchorage-dependent growth of bone marrow fibroblasts. Strongest increase of OCP-like cells occurred in monolayer cultures in the absence of CSF-1. Dermal fibroblasts of fetal mice did not enhance OCP-like cell growth. OCP-like cell density was strongly correlated with the number of osteoclast nuclei formed in cocultures with periost-free bone rudiments. These data indicate that mononuclear cells, cytochemically and functionally resembling osteoclast precursors, may be grown from mouse bone marrow. CSF-1 inhibited growth of OCP-like cells, indicating that osteoclast precursors differ from mononuclear phagocytes in growth requirements.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3509797

Source DB:  PubMed          Journal:  Bone Miner        ISSN: 0169-6009


  8 in total

1.  The in vivo role of bone marrow fibroblast-like stromal cells.

Authors:  D J Simmons
Journal:  Calcif Tissue Int       Date:  1996-03       Impact factor: 4.333

2.  Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse.

Authors:  W Wiktor-Jedrzejczak; A Bartocci; A W Ferrante; A Ahmed-Ansari; K W Sell; J W Pollard; E R Stanley
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

3.  The role of macrophage stimulating factor M-CSF in bone resorption.

Authors:  H Fleisch; W Hofstetter; R Felix; M Cecchini; A Wetterwald
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

4.  Establishment and characterization of stromal cell lines that support differentiation of murine hematopoietic blast cells into osteoclast-like cells.

Authors:  H Takanashi; T Matsuishi; K Yoshizato
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-06       Impact factor: 2.416

5.  Detection of transcripts for the receptor for macrophage colony-stimulating factor, c-fms, in murine osteoclasts.

Authors:  W Hofstetter; A Wetterwald; M C Cecchini; R Felix; H Fleisch; C Mueller
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

6.  Colony-stimulating factor-1 (CSF-1) directly inhibits receptor activator of nuclear factor-{kappa}B ligand (RANKL) expression by osteoblasts.

Authors:  Y Wittrant; Y Gorin; S Mohan; B Wagner; S L Abboud-Werner
Journal:  Endocrinology       Date:  2009-10-09       Impact factor: 4.736

7.  Histochemistry of tartrate-resistant acid phosphatase and carbonic anhydrase isoenzyme II in osteoclast-like giant cells in bone tumours.

Authors:  S Toyosawa; Y Ogawa; C K Chang; S S Hong; T Yagi; H Kuwahara; K Wakasa; M Sakurai
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

8.  Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor.

Authors:  H Kodama; A Yamasaki; M Nose; S Niida; Y Ohgame; M Abe; M Kumegawa; T Suda
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.